Remote patient monitoring may reduce technique failure for patients using automated PD
Click Here to Manage Email Alerts
Key takeaways:
- Technique failure was notably lower for individuals on remote monitoring.
- The incidence rate ratio of technique failure was 0.45, with a 95% confidence interval.
A remote patient monitoring program for adults on automated peritoneal dialysis may lead to a lower technique failure rate, according to findings from a recently published observational study.
“Remote patient monitoring (RPM) programs in automated peritoneal dialysis (APD) allow clinical teams to be aware of many aspects and events of the therapy that occur in the home,” Leyder Corzo, of the renal therapy services division at the Instituto Nacional del Riñón in Bogotá, Colombia, and colleagues wrote in Peritoneal Dialysis International. “The present study evaluated the association between RPM use and APD technique failure.”
Investigators conducted a multicenter trial at the Renal Therapy Services Network in Colombia and followed 558 patients using automated PD from October 2016 to June 2017. The cohort was categorized into two groups based on RPM usage: automated PD with remote patient monitoring and automated PD without such monitoring. Overall, 26.5% of patients used automated PD with RPM. Researchers tracked outcomes until June 2018 and summarized patient sociodemographic and clinical characteristics, ensuring balance with a propensity score. Potential links between remote patient monitoring and technique failure were estimated after adjusting for events such as death and kidney transplantation.
In a matched sample of 148 patients on automated PD with remote patient monitoring and 148 patients on PD without such monitoring, the technique failure rate of 0.08 episodes per patient-year in the former group was lower than the 0.18 rate for the latter, according to the findings. The incidence rate ratio was 0.45, with a 95% confidence interval and a statistically significant P value of .03.
“RPM programs have several theoretical and demonstrated clinical advantages that could be paths through which this technology can improve outcomes, such as early diagnosis of catheter dysfunction, lower incidence of peritonitis, achieving a better therapy adherence and improvements in reaching ultrafiltration goals,” Corzo and colleagues wrote.
While further work may expand outreach and measure other patient outcomes, the study supports the notion that “this type of technology can be an important contributor to achieving better health outcomes for the PD population,” they wrote.
Collapse
Read more about
Click Here to Manage Email Alerts